Human FABP1 T94A variant enhances cholesterol uptake

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 7, 2015, Pages 946-955

  Huang, Huan ^a   McIntosh, Avery L ^a   Landrock, Kerstin K ^b   Landrock, Danilo ^b   Storey, Stephen M ^a   Martin, Gregory G ^a   Gupta, Shipra ^c   Atshaves, Barbara P ^c   Kier, Ann B ^b   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Michigan State University   (United States)

Author keywords

Cholesterol uptake; Hepatocyte; Human FABP1; Lipoprotein

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN T94A; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN VARIANT; SCAVENGER RECEPTOR BI; STEROL CARRIER PROTEIN 2; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; ALANINE; CHOLESTEROL; FABP1 PROTEIN, HUMAN; THREONINE;

ADULT; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; LIVER CELL; MICROCALORIMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; THERMODYNAMICS; UPREGULATION; AMINO ACID SUBSTITUTION; ANIMAL; CELL CULTURE; GENETICS; LIPID METABOLISM; METABOLISM; MISSENSE MUTATION; TRANSPORT AT THE CELLULAR LEVEL;

ALANINE; AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; FATTY ACID-BINDING PROTEINS; FEMALE; HEPATOCYTES; HUMANS; LIPID METABOLISM; MIDDLE AGED; MUTATION, MISSENSE; THREONINE;

EID: 84925825871     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.02.015     Document Type: Article

References (66)

1. M.E. Haberland, and J.A. Reynolds Self-association of cholesterol in aqueous solution Proc. Natl. Acad. Sci. 70 1973 2313 2318
2. B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, and M. Barbalic Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 2012 572 580
3. M. Navab, G.M. Anantharamaiah, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL as a biomarker, potential therapeutic target, and therapy Diabetes 58 2009 2711 2717
4. E.J. Schaefer, R.D. Santos, and B.F. Asztalos Marked HDL deficiency and premature coronary heart disease Curr. Opin. Lipidol. 21 2010 289 297
5. R. Frikke-Schmidt Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population Atherosclerosis 208 2010 305 316
6. M.J. McArthur, B.P. Atshaves, A. Frolov, W.D. Foxworth, A.B. Kier, and F. Schroeder Cellular uptake and intracellular trafficking of long chain fatty acids J. Lipid Res. 40 1999 1371 1383
7. F. Favretto, M. Assfalg, M. Gallo, D.O. Cicero, M. D'Onofrio, and H. Molinari Ligand binding promiscuity and human liver fatty acid binding protein: structural and dynamic insights from an interaction study with glycocholate and oleate ChemBioChem 14 2013 1807 1819
8. G. Nemecz, and F. Schroeder Selective binding of cholesterol by recombinant fatty acid-binding proteins J. Biol. Chem. 266 1991 17180 17186
9. G.G. Martin, B.P. Atshaves, H. Huang, A.L. McIntosh, B.W. Williams, P.-J. Pai, D.H. Russell, A.B. Kier, and F. Schroeder Hepatic phenotype of liver fatty acid binding protein (L-FABP) gene ablated mice Am. J. Physiol. 297 2009 G1053 G1065
10. R.T. Fischer, M.S. Cowlen, M.E. Dempsey, and F. Schroeder Fluorescence of delta 5,7,9(11),22-ergostatetraen-3 beta-ol in micelles, sterol carrier protein complexes, and plasma membranes Biochemistry 24 1985 3322 3331
11. J. Yan, Y. Gong, Y.-M. She, G. Wang, M.S. Roberts, and F.J. Burczynski Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity J. Lipid Res. 50 2009 2445 2454
12. J. Yan, Y. Gong, Y.M. She, G. Wang, M.S. Robertes, and F.J. Burczynski Molecular mechanism of recombinant L-FABP's antioxidant activity J. Lipid Res. 50 2010 2445 2454
13. G.V. Richieri, R.T. Ogata, and A.M. Kleinfeld Equilibrium constants for the binding of fatty acids with fatty acid binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB J. Biol. Chem. 269 1994 23918 23930
14. A. Frolov, J.K. Woodford, E.J. Murphy, J.T. Billheimer, and F. Schroeder Spontaneous and protein-mediated sterol transfer between intracellular membranes J. Biol. Chem. 271 1996 16075 16083
15. A.A. Frolov, J.K. Woodford, E.J. Murphy, J.T. Billheimer, and F. Schroeder Fibroblast membrane sterol kinetic domains: modulation by sterol carrier protein 2 and liver fatty acid binding protein J. Lipid Res. 37 1996 1862 1874
16. J.K. Woodford, W.D. Behnke, and F. Schroeder Liver fatty acid binding protein enhances sterol transfer by membrane interaction Mol. Cell. Biochem. 152 1995 51 62
17. J.R. Jefferson, J.P. Slotte, G. Nemecz, A. Pastuszyn, T.J. Scallen, and F. Schroeder Intracellular sterol distribution in transfected mouse L-cell fibroblasts expressing rat liver fatty acid binding protein J. Biol. Chem. 266 1991 5486 5496
18. S.M. Storey, A.L. McIntosh, H. Huang, G.G. Martin, K.K. Landrock, D. Landrock, H.R. Payne, A.B. Kier, and F. Schroeder Intracellular cholesterol binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G824 G839
19. H. Huang, A.L. McIntosh, G.G. Martin, K. Landrock, D. Landrock, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Structural and functional interaction of fatty acids with human liver fatty acid binding protein (L-FABP) T94A variant FEBS J. 281 2014 2266 2283
20. G.G. Martin, A.L. McIntosh, H. Huang, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Human liver fatty acid binding protein (L-FABP) T94A variant alters structure, stability, and interaction with fibrates Biochemistry 52 2013 9347 9357
21. R.G. Maatman, E.M. van de Westerlo, T.H. Van Kuppevelt, and J.H. Veerkamp Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction Biochem. J. 288 1992 285 290
22. C. Wolfrum, T. Borchers, J.C. Sacchettini, and F. Spener Binding of fatty acids and perooxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver Biochemistry 39 2000 1469 1474
23. B.P. Atshaves, H.R. Payne, A.L. McIntosh, S.E. Tichy, D. Russell, A.B. Kier, and F. Schroeder Sexually dimorphic metabolism of branched chain lipids in C57BL/6J mice J. Lipid Res. 45 2004 812 830
24. B.P. Atshaves, A.L. McIntosh, H.R. Payne, J. Mackie, A.B. Kier, and F. Schroeder Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene Am. J. Physiol. 288 2005 C543 C558
25. B.P. Atshaves, A.L. McIntosh, D. Landrock, H.R. Payne, J. Mackie, N. Maeda, J.M. Ball, F. Schroeder, and A.B. Kier Effect of SCP-x gene ablation on branched-chain fatty acid metabolism Am. J. Physiol. 292 2007 939 951
26. B.P. Atshaves, A.L. McIntosh, G.G. Martin, D. Landrock, H.R. Payne, S. Bhuvanendran, K. Landrock, O.I. Lyuksyutova, J.D. Johnson, R.D. Macfarlane, A.B. Kier, and F. Schroeder Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice J. Lipid Res. 50 2009 1429 1447
27. X.-E. Peng, Y.L. Wu, Q.-Q. Lu, Z.-J. Ju, and X. Lin Two genetic variants in FABP1 and susceptibility to non-alcoholic fatty liver disease in a Chinese population Gene 500 2012 54 58
28. E. Fisher, C. Weikert, M. Klapper, I. Lindner, M. Mohlig, J. Spranger, H. Boeing, J. Schrezenmeir, and F. Doring L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women Mol. Genet. Metab. 91 2007 278 284
29. C. Brouillette, Y. Bose, L. Perusse, D. Gaudet, and M.-C. Vohl Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate J. Hum. Genet. 49 2004 424 432
30. B. Verges Lipid modification in type 2 diabetes: the role of LDL and HDL Fundam. Clin. Pharmacol. 23 2009 685
31. E.C.R. Quintao, W.L. Medina, and M. Passarelli Reverse cholesterol transport in diabetes mellitus Diabetes Metab. Res. Rev. 16 2000 237 250
32. M. Passarelli, A.F.M. Shimabukuro, S. Catanozi, E.R. Nakandakare, J.C. Rocha, A.J.F. Carrilho, and E.C.R. Quintao Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus Clin. Chim. Acta 301 2000 119 134
33. Y. Yamada, K. Kato, M. Oguri, T. Yoshida, K. Yokoi, S. Watanabe, N. Metoki, H. Yoshida, K. Satoh, S. Ichihara, Y. Aoyagi, A. Yasunaga, H. Park, M. Tanaka, and Y. Nozawa Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome Int. J. Mol. Med. 21 2008 801 808
34. A.L. McIntosh, H. Huang, S.M. Storey, K. Landrock, D. Landrock, A.D. Petrescu, S. Gupta, B.P. Atshaves, A.B. Kier, and F. Schroeder Human FABP1 T94A variant impacts fatty acid metabolism and PPARa activation in cultured human female hepatocytes Am. J. Physiol. Gastrointest. Liver Physiol. 307 2014 G164 G176
35. N. Gao, X. Qu, J. Yan, Q. Huang, H.Y. Yuan, and D.-S. Ouyang L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP Mol. Cell. Biochem. 345 2010 207 214
36. B.P. Atshaves, A. Petrescu, O. Starodub, J. Roths, A.B. Kier, and F. Schroeder Expression and intracellular processing of the 58 kDa sterol carrier protein 2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts J. Lipid Res. 40 1999 610 622
37. A. Frolov, T.H. Cho, E.J. Murphy, and F. Schroeder Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs Biochemistry 36 1997 6545 6555
38. N.A. Avdulov, S.V. Chochina, U. Igbavboa, C.H. Warden, F. Schroeder, and W.G. Wood Lipid binding to sterol carrier protein-2 is inhibited by ethanol Biochim. Biophys. Acta 1437 1999 37 45
39. F. Schroeder, A. Frolov, J. Schoer, A. Gallegos, B.P. Atshaves, N.J. Stolowich, A.I. Scott, and A.B. Kier Intracellular sterol binding proteins, cholesterol transport and membrane domains T.Y. Chang, D.A. Freeman, Intracellular Cholesterol Trafficking 1998 Kluwer Academic Publishers Boston 213 234
40. 13C-NMR investigation of cholesterol and fatty acid binding sites J. Biol. Chem. 274 1999 35425 35433
41. R. Liu, P. Lu, J.W.K. Chu, and F.J. Sharom Characterization of fluorescent sterol binding to purified human NPC1 J. Biol. Chem. 284 2009 1840 1852
42. N.A. Avdulov, S.V. Chochina, U. Igbavboa, C.S. Warden, A. Vassiliev, and G.W. Wood Lipid binding to amyloid B-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids J. Neurochem. 69 1997 1746 1752
43. E. Reaven, L. Tsai, and S. Azhar Cholesterol uptake by the selective pathway of ovarian granulosa cells: early intracellular events J. Lipid Res. 36 1995 1602 1617
44. A. Frolov, A. Petrescu, B.P. Atshaves, P.T.C. So, E. Gratton, G. Serrero, and F. Schroeder High density lipoprotein mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts J. Biol. Chem. 275 2000 12769 12780
45. B.P. Atshaves, O. Starodub, A.L. McIntosh, J.B. Roths, A.B. Kier, and F. Schroeder Sterol carrier protein-2 alters HDL-mediated cholesterol efflux J. Biol. Chem. 275 2000 36852 36861
46. S.M. Storey, B.P. Atshaves, A.L. McIntosh, K.K. Landrock, G.G. Martin, H. Huang, J.D. Johnson, R.D. Macfarlane, A.B. Kier, and F. Schroeder Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from primary cultured mouse hepatocytes Am. J. Physiol. 299 2010 244 254
47. G. Dagher, N. Donne, C. Klein, P. Ferre, and I. Dugail HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes J. Lipid Res. 44 2003 1811 1820
48. C.P. Sparrow, S. Patel, J. Baffic, Y.-S. Chao, M. Hernandez, M.-H. Lam, J. Montenegro, S.D. Wright, and P.A. Detmers A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro J. Lipid Res. 40 1999 1747 1757
49. B.P. Atshaves, A.L. McIntosh, O.I. Lyuksyutova, W.R. Zipfel, W.W. Webb, and F. Schroeder Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes J. Biol. Chem. 279 2004 30954 30965
50. A.L. McIntosh, B.P. Atshaves, H.A. Hostetler, H. Huang, J. Davis, O.I. Lyuksyutova, D. Landrock, A.B. Kier, and F. Schroeder Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator activated receptor-alpha activity in cultured primary hepatocytes Arch. Biochem. Biophys. 485 2009 160 173
51. S. Takahashi, J. Sakai, T. Fujino, H. Hattori, Y. Zenimary, J. Suzuki, I. Miyamori, and T.T. Yamamoto The very low density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor J. Atheroscler. Thromb. 11 2004 200 208
52. F. Schroeder, S.C. Myers-Payne, J.T. Billheimer, and W.G. Wood Probing the ligand binding sites of fatty acid and sterol carrier proteins: effects of ethanol Biochemistry 34 1995 11919 11927
53. X. Galan, J. Peinado-Onsurbe, J. Julve, D. Ricart-Jane, M.Q. Robert, M. Llobera, and I. Ramirez Inactive hepatic lipase in rat plasma J. Lipid Res. 44 2003 2250 2256
54. B. Perret, L. Mabile, L. Martinez, F. Terce, R. Barabas, and X. Collet Hepatic lipase: structure/function relationship, synthesis, and regulation J. Lipid Res. 43 2002 1163 1169
55. M.A. Connelly, and D.L. Williams Scavenger receptor B1: a scavenger receptor with a mission to transport high density lipoprotein lipids Curr. Opin. Lipidol. 15 2004 287 295
56. A. Rigotti, H. Miettinen, and M. Kreiger The role of the high-density lipoprotein receptor SR-B1 in the lipid metabolism of endocrine and other tissues Endocr. Rev. 23 2003 357 383
57. M. Calvo, D. Gomez-Coronado, M.A. Lasuncion, and M.A. Vega CLA-1 is an 85 kD plasma membrane glycoprotein that acts as a high affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins Arterioscler. Thromb. Vasc. Biol. 17 1997 2341 2349
58. S.L. Acton, P.E. Scherer, H.F. Lodish, and M. Krieger Expression cloning of SR-B1, a CD36-related class B scavenger receptor J. Biol. Chem. 269 1994 21003 21009
59. M. de la Llera-Moya, G.H. Rothblat, M.A. Connelly, G. Kellner-Weibel, S.W. Sakr, M.C. Phillips, and D.L. Williams Scavenger receptor B1 (SRB1) mediates free cholesterol flux independently of HDL tethering to the surface J. Lipid Res. 40 1999 575 580
60. K. Murao, V. Terpstra, S.R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger Characterization of CLA-1, a human homologue of rodent scavenger receptor B1, as a receptor for high density lipoprotein and apoptotic thymocytes J. Biol. Chem. 272 1997 17551 17557
61. M. Krieger Charting the fate of the "good cholesterol": identification and characterization of the high density lipoprotein receptor SR-B1 Ann. Rev. Biochem. 68 1999 523 558
62. M. Van Eck, M. Hoekstra, R. Out, I.S.T. Bos, J.K. Van Kruijt, R.B. Hildebrand, and T.J.C. Van Berkel SRB1 facilitates the metabolism of VLDL lipoproteins in vivo J. Lipid Res. 49 2008 136 146
63. C. Rohrl, S. Fruhwurth, S.M. Schreier, and A. Lohninger SRB1 provides an alternative means for b-VLDL uptake independent of the LDL receptor in tissue culture Biochim. Biophys. Acta 1801 2010 198 204
64. M. Furuhashi, G. Tuncman, C.Z. Gorgun, L. Makowski, G. Atsumi, E. Vallaincourt, K. Kono, V.R. Babaev, S. Fazio, M.F. Linton, R. Sulsky, J.A. Robl, R.A. Parker, and G.S. Hotamisligil Treatment of diabetes and atherosclerosis by inhibiting fatty acid binding protein aP2 Nature 447 2008 959 965
65. T. Kriska, A. Pilat, J.C. Schmitt, and A.W. Girotti Sterol carrier protein-2 (SCP-2) involvement in cholesterol hydroperoxide cytotoxicity as revealed by SCP-2 inhibitor effects. J. Lipid Res. 51 2010 3184
66. M.-S. Kim, V. Wessely, and Q. Lan Identification of mosquito sterol carrier protein-2 inhibitors J. Lipid Res. 46 2005 650 657